quadraScope Venture Fund

About quadraScope Venture Fund

quadraScope Venture Fund is an investment firm specializing in the biotechnology and pharmaceutical sector with a strong focus on advancing healthcare through innovative solutions targeting the biological basis of aging.

Their investment thesis is centered around supporting healthcare companies that are developing a spectrum of products, including pharmaceuticals, diagnostics, software, equipment, and devices, all contributing towards disease treatment and prevention through biological age reversal.

The fund seeks to invest in opportunities that leverage new scientific insights into the Hallmarks of Aging, a framework introduced and expanded upon by leading researchers in the field of biogerontology, with the objective of extending human healthspan. quadraScope's portfolio encompasses a diverse array of projects, such as rejuvenating the immune system through stem cell secretomes, creating nanomachines for protein removal, cellular rejuvenation therapies, regenerative collagen applications, personalized medicine utilizing machine learning, DNA repair technologies, targeting specific senescent cells, cholesterol degradation systems, mitochondrial health enhancement, and development of human organoids.

They have a specific interest in the new wave of rejuvenation industry technologies and are strategically situated in the biotech hubs of Boston and Tel-Aviv to tap into a pool of scientific talent and academia.

The investment fund operates within a range of $100,000 to $1,000,000, with a sweet spot of around $300,000 for its investments, and primarily engages in Pre-Seed and Seed-stage funding. The team at quadraScope is women-led and possesses a track record of successful new venture development through to profitable exits.

Their leadership includes a managing partner, a scientific director, along with scientific and business advisory boards composed of industry experts and veterans. The fund actively supports its portfolio companies and engages with strategic partners who align with their vision of extending lifespan and health-span, thus making meaningful strides in the longevity science market.